Neuropil < Neuroprotective Agents < Neuropsychological Tests

Facettes :

List of bibliographic references indexed by Neuroprotective Agents

Number of relevant bibliographic references: 65.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000404 (2014)	Andrew B. West	Ten Years and Counting: Moving Leucine-Rich Repeat Kinase 2 Inhibitors to the Clinic
000453 (2014)	Robert A. Hauser [États-Unis] ; Dee Silver ; Azhar Choudhry ; Eli Eyal ; Stuart Isaacson	Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease.
000459 (2014)	Abhishek Chandra ; Ashu Johri ; M. Flint Beal	Prospects for Neuroprotective Therapies in Prodromal Huntington's disease
000714 (2013)	Anthony E. Lang [Canada] ; Eldad Melamed ; Werner Poewe [Autriche] ; Olivier Rascol	Trial designs used to study neuroprotective therapy in Parkinson's disease.
000725 (2013)	C Warren Olanow [États-Unis] ; Jose A. Obeso ; Fabrizio Stocchi	The vatican meeting on neuroprotection for Parkinson's disease.
000789 (2013)	Katherine L. Possin ; Gail A. Kang ; Christine Guo ; Eric M. Fine ; Andrew J. Trujillo ; Caroline A. Racine ; Reva Wilheim ; Erica T. Johnson ; Jennifer L. Witt ; William W. Seeley ; Bruce L. Miller ; Joel H. Kramer	Rivastigmine is Associated with Restoration of Left Frontal Brain Activity in Parkinson’s Disease
000862 (2013)	C Warren Olanow [États-Unis] ; Patrik Brundin	Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
000873 (2013)	Fabrizio Stocchi [Italie] ; C Warren Olanow	Obstacles to the development of a neuroprotective therapy for Parkinson's disease.
000922 (2013)	Radu Constantinescu [États-Unis] ; Jordan Elm [États-Unis] ; Peggy Auinger [États-Unis] ; Saloni Sharma [États-Unis] ; Erika F. Augustine [États-Unis] ; Laith Khadim [États-Unis] ; Karl Kieburtz [États-Unis]	Malignant Melanoma in Early-Treated Parkinson's Disease: The NET-PD Trial
000A01 (2013)	Fanny Duval [France] ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François Tison	Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
000A07 (2013)	Antje Haehner ; Thomas Hummel ; Martin Wolz ; Lisa Klingelhöfer ; Mareike Fauser ; Alexander Storch ; Heinz Reichmann	Effects of rasagiline on olfactory function in patients with Parkinson’s disease.
000A86 (2013)	Pankaj A. Agarwal [Canada] ; A Jon Stoessl	Biomarkers for trials of neuroprotection in Parkinson's disease.
000C54 (2012)	Johannes R. Streffer [Belgique] ; Igor D. Grachev ; Cheryl Fitzer-Attas ; Baltazar Gomez-Mancilla ; Babak Boroojerdi ; Juliana Bronzova ; Susanne Ostrowitzki ; Stephen J. Victor ; Paulo Fontoura ; Robert Alexander	Prerequisites to launch neuroprotective trials in Parkinson's disease: an industry perspective.
000C63 (2012)	Charles S. Venuto [États-Unis] ; Andrew Mcgarry ; Qing Ma ; Karl Kieburtz	Pharmacologic approaches to the treatment of Huntington's disease.
000C94 (2012)	Paolo Calabresi [Italie] ; Massimiliano Di Filippo [Italie] ; Antongiulio Gallina [Italie] ; Yingfei Wang [États-Unis] ; Jeannette N. Stankowski [États-Unis] ; Barbara Picconi [Italie] ; Valina L. Dawson [États-Unis] ; Ted M. Dawson [États-Unis]	New Synaptic and Molecular Targets for Neuroprotection in Parkinson’s Disease
000E87 (2012)	Erwan Bezard [France] ; Zhenyu Yue [États-Unis] ; Deniz Kirik [Suède] ; Maria Grazia Spillantini [Royaume-Uni]	Animal Models of Parkinson’s Disease: limits and relevance to neuroprotection studies
001050 (2012)	Maryka Quik [États-Unis] ; Xiomara A. Perez [États-Unis] ; Tanuja Bordia [États-Unis]	Nicotine as a Potential Neuroprotective Agent for Parkinson's Disease
001271 (2011)	Alessandra Nicoletti [Italie] ; Giovanni Mostile [Italie] ; Roberto Cappellani [Italie] ; Donatella Contrafatto [Italie] ; Gennarina Arabia [Italie] ; Paolo Lamberti [Italie] ; Roberto Marconi [Italie] ; Letterio Morgante [Italie] ; Paolo Barone [Italie] ; Aldo Quattrone [Italie] ; Mario Zappia [Italie]	Wine drinking and essential tremor: A possible protective role
001331 (2011)	Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; P Nar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie]	The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study
001363 (2011)	Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada]	Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease
001403 (2011)	Alfonso Fasano [Italie] ; Alessandro Di Matteo [Italie] ; Carmine Vitale [Italie] ; Giovanna Squintani [Italie] ; Laura Ferigo [Italie] ; Federica Bombieri [Italie] ; Gabriella Santangelo [Italie] ; Marianna Amboni [Italie] ; Paolo Barone [Italie] ; Michele Tinazzi [Italie]	Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Neuroprotective Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Neuroprotective Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Neuroprotective Agents
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024